Global Nuclear Imaging Devices Market to Witness Increased Revenue Growth Owing to Rapid Increase in Demand by 2027
Market Highlights
The global nuclear imaging
devices market is expected to grow significantly over the forecast period.
It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.
The increasing prevalence of cardiovascular disorders is one
of the key factors driving the nuclear imaging devices market. As per the
report published by the Centers for Disease Control and Prevention (CDC) in
2017, nearly 92.1 million adults were dealing with at least one type of
cardiovascular disease.
Various other factors such as the advancements in radiotracers,
acceptance of nuclear imaging devices in ambulatory settings, increasing
geriatric population, untapped emerging markets, rise in regulatory approvals,
and increasing investment on diagnostic imaging centers are also expected to
propel the growth of the market.
However, the high cost of the nuclear
imaging device, shorter half-life of radiopharmaceuticals can hamper
market growth over the forecast period.
Segmentation
The global nuclear imaging devices market is segmented based on
technology, application, end user, and region.
The global market for nuclear imaging devices, by technology, is
segmented into positron emission tomography (PET), single photon emission
computed tomography (SPECT), and planar scintigraphy. The
single-photon-emission computed tomography (SPECT) are further classified as
hybrid SPECT systems and standalone SPECT systems.
Based on application, the market is segmented into oncology, cardiology,
neurology, and others.
Based on end user, the market is segmented into hospitals, diagnostic
imaging centers, and others.
The diagnostic imaging centers segment is expected to witness the
fastest growth over the forecast period due to rising adoption of nuclear
imaging in diagnostic centers.
Key Players
Some of the key
players in the global nuclear imaging devices market are Philips Healthcare,
Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics
Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical
Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company,
DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and
others.
Access Report Details @ https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014
Regional Analysis
In the current scope of the study, the segments mentioned above are
covered into the four global regions, namely, the Americas, Europe,
Asia-Pacific, and the Middle East and African region.
The nuclear imaging devices market in the Americas has further been
segmented into North America and South America, with the North American market
divided into the US and Canada.
The European nuclear imaging devices market has been segmented into
Western Europe and Eastern Europe. Western Europe has been classified as
Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The nuclear imaging devices market in Asia-Pacific has been segmented into
Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The
nuclear imaging devices market in the Middle East & Africa has been
segmented into the Middle East and Africa.
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on
Various Industry Verticals and wherever required we will be considering Covid19
Footprints for Better Analysis of Market and Industries. Cordially get in Touch
for More Details.
Comments
Post a Comment